Creation of a drug fund for post-clinical trial access to antiretrovirals

Lancet

Volumn 364, Issue 9428, 2004, Pages 101-102

  Ananworanich, Jintanat ^a   Cheunyam, Theshinee ^a   Teeratakulpisarn, Somsong ^a   Boyd, Mark A ^a   Ruxrungtham, Kiat ^a   Lange, Prof Joep ^a   Cooper, Prof David ^a   Phanuphak, Prof Praphan ^a  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BUDGET; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; EPIDEMIC; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MALARIA; PRIORITY JOURNAL; PURCHASING; QUALITY OF LIFE; SHORT SURVEY; SOCIAL WORKER; THAILAND; TUBERCULOSIS; UNITED STATES; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; ECONOMICS; ETHICS; HEALTH CARE AND PUBLIC HEALTH; HEALTH CARE DELIVERY; MEDICAL ETHICS;

BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH;

ANTI-RETROVIRAL AGENTS; CLINICAL TRIALS; FINANCIAL MANAGEMENT; HEALTH SERVICES ACCESSIBILITY; HELSINKI DECLARATION; HIV INFECTIONS; HUMANS;

EID: 3042784270     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16596-3     Document Type: Note

References (9)

1. Frankish H. WMA postpones decision to amend Declaration of Helsinki. Lancet. 362:2003;963
2. Angell M. Investigators' responsibilities for human subjects in developing countries. N Engl J Med. 342:2000;967-969
3. Lo B, Bayer R. Establishing ethical trials for treatment and prevention of AIDS in developing countries. BMJ. 327:2003;337-339
4. Fitzgerald DW, Pape JW, Wasserheit JN, Counts GW, Corey L. Provision of treatment in HIV-1 vaccine trials in developing countries. Lancet. 362:2003;993-994
5. Kunanusont C, Phoolcharoen W, Bodaramik Y. Evolution of medical services for HIV/AIDS in Thailand. J Med Assoc Thai. 82:1999;425-434
6. Vermund SH, Powderly WG. Developing a human immunodeficiency virus/acquired immunodeficiency syndrome therapeutic research agenda for resource-limited countries: a consensus statement. Clin Infect Dis. 37:2003;4-12
7. Berkley S. Thorny issues in the ethics of AIDS vaccine trials. Lancet. 362:2003;992
8. Klausner RD, Fauci AS, Corey L, et al. Medicine. The need for a global HIV vaccine enterprise. Science. 300:2003;2036-2039
9. Tucker T, Slack C. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa. Lancet. 362:2003;995